ClassID:

92522

C07C215/18 - CPC Classification

Classification description:

Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with hydroxy groups and at least two amino groups bound to the carbon skeleton

Recent Application in this class:
#1
20250269387
2025-08-28

METHOD FOR FLOTATION OF A SILICATE-CONTAINING IRON ORE WITH A CATIONIC COLLECTOR

#2
20220212204
2022-07-07

Method for flotation of a silicate-containing iron ore with a cationic collector

#3
20220153685
2022-05-19

Small molecule AMPK activators

#4
20220009877
2022-01-13

Methods for producing (6S,15S)-3,8,13,18-tetraazaicosane-6,15-diol

#5
20210009504
2021-01-14

Methods for producing (6S,15S)-3,8,13,18-tetraazaicosane-6,15-diol

#6
20200254380
2020-08-13

Absorbent solution based on hydroxyl derivatives of 1,6-hexanediamine and method for eliminating acid compounds from a gaseous effluent

#7
20200062693
2020-02-27

Small molecule AMPK activators

#8
20190292131
2019-09-26

Method for making end compounds from internal ketones issued from the decarboxylative ketonization of fatty acids or fatty acid derivatives

#9
20180251421
2018-09-06

Beta-hydroxylated tertiary diamines, a process for their synthesis and their use for eliminating acid compounds a gaseous effluent

#10
20170081275
2017-03-23

NOVEL BETA-HYDROXYLATED TERTIARY DIAMINES, A PROCESS FOR THEIR SYNTHESIS AND THEIR USE FOR ELIMINATING ACID COMPOUNDS A GASEOUS EFFLUENT

#11
20150332803
2015-11-19

Hydroxy compound, ion conducting agent, and electroconductive resin composition

#12
20140107376
2014-04-17

Dendrimers and methods for their preparation

#13
20130137772
2013-05-30

HYDROXYPOLYAMINE SALTS

#14
20130022553
2013-01-24

Polyamino polyketide antibiotics and uses thereof

#15
20120316359
2012-12-13

Biological buffers with wide buffering ranges

#16
20120202934
2012-08-09

Method for preparing polyamine compounds

#17
20120165521
2012-06-28

Low-VOC polyamino alcohols

#18
20120034270
2012-02-09

S1P receptors modulators

#19
20110275673
2011-11-10

INHIBITORS OF SPHINGOSINE KINASE 1

#20
20110251289
2011-10-13

NEW COMPOUNDS FOR THE TREATMENT OF CANCER

#21
20110152574
2011-06-23

Diamino-alcohol compounds and processes for their manufacture

#22
20100240894
2010-09-23

METHOD FOR PRODUCING AMINES FROM GLYCERIN

#23
20100183732
2010-07-22

One step process for preparing cross-linked poly(allylamine) polymers

#24
20090264675
2009-10-22

Biological buffers with wide buffering ranges

#25
20090264651
2009-10-22

Biological buffers with wide buffering ranges

#26
20090124832
2009-05-14

OLIGOAMINE COMPOUNDS AND DERIVATIVES THEREOF FOR CANCER THERAPY

#27
20090030085
2009-01-29

Use of bis-amines to enhance the antimicrobial activity of aqueous compositions

#28
20080045470
2008-02-21

Ceramides and apoptosis-signaling ligand

#29
20070135648
2007-06-14

Method for producing optically active alcohols or carboxylic acids

#30
20070015818
2007-01-18

Cyclic sulfone containing retroviral protease inhibitors

#31
20070011827
2007-01-18

Novel double para-phenylenediamines joined by a linker arm substituted with at least one group chosen from hydroxyl, alkoxy, and/or amino groups and method of dyeing keratinous fibers

#32
20060275873
2006-12-07

Autoinducer compound to improve the productivity of natamycin streptomyces strains

#33
20060270855
2006-11-30

Methods of preparing retroviral proteases inhibitor intermediates

#34
20050154065
2005-07-14

Use of bis-amines to enhance the antimicrobial activity of aqueous compositions

#35
20050131075
2005-06-16

Method of preparing retroviral protease inhibitor intermediates

#36
20050101676
2005-05-12

Amino thiol compounds and compositions for use in conjunction with cancer therapy

#37
20050100527
2005-05-12

Compounds for delivering substances into cells

#38
20050080144
2005-04-14

Oligoamine compounds and derivatives thereof for cancer therapy

#39
20050027016
2005-02-03

Polyamine compounds and compositions for use in conjection with cancer therapy